Persistent indirect airway hyperresponsiveness after six weeks of high-dose inhaled corticosteroids identifies a subgroup with higher T2 inflammation and mast cell burden.

Bari EJ, Sverrild A, Eriksen LL, Frøssing L, Erjefält JS, Porsbjerg C, Hvidtfeldt M

Open source

DOI
10.1016/j.jaci.2026.09.036
Published
2026 Nov 3
Container
The Journal of allergy and clinical immunology
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jaci.2026.09.036,
  title = {Persistent indirect airway hyperresponsiveness after six weeks of high-dose inhaled corticosteroids identifies a subgroup with higher T2 inflammation and mast cell burden.},
  author = {Bari EJ and Sverrild A and Eriksen LL and Frøssing L and Erjefält JS and Porsbjerg C and Hvidtfeldt M},
  year = {2026},
  journal = {The Journal of allergy and clinical immunology},
  doi = {10.1016/j.jaci.2026.09.036},
  url = {https://doi.org/10.1016/j.jaci.2026.09.036}
}

RIS

TY  - JOUR
TI  - Persistent indirect airway hyperresponsiveness after six weeks of high-dose inhaled corticosteroids identifies a subgroup with higher T2 inflammation and mast cell burden.
AU  - Bari EJ
AU  - Sverrild A
AU  - Eriksen LL
AU  - Frøssing L
AU  - Erjefält JS
AU  - Porsbjerg C
AU  - Hvidtfeldt M
PY  - 2026
JO  - The Journal of allergy and clinical immunology
DO  - 10.1016/j.jaci.2026.09.036
UR  - https://doi.org/10.1016/j.jaci.2026.09.036
ER  - 

APA

EJ, B., A, S., LL, E., L, F., JS, E., C, P., & M, H. (2026). Persistent indirect airway hyperresponsiveness after six weeks of high-dose inhaled corticosteroids identifies a subgroup with higher T2 inflammation and mast cell burden.. The Journal of allergy and clinical immunology. https://doi.org/10.1016/j.jaci.2026.09.036

Source records